Moreover, we also analyzed the correlation between RBM15 expression and patient’ PFI, and found that abnormal RBM15 expression affected patients’ PFI in 12 cancer types, including ACC, CHOL, GBM, KICH, KIRC, KIRP, LGG, LIHC, PAAD, READ, UCEC and UVM (Figure 5A). Here, RBM15 is linked to glioblastoma.